Hyoscine Trial

Hyoscine Butyl-Bromide versus Placebo in Nulliparous Women in Labour: A Randomized Controlled Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202409867055348

Enrollment

180

Registered

2024-09-13

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour management

Interventions

Hyoscine Butyl bromide group

Placebo group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Primigravida in labour Singleton pregnancy in cephalic presentation No contraindication to vaginal delivery Signed informed consent form

Exclusion criteria

Exclusion criteria: Multiparous women Multiple gestation Any contraindication to vaginal delivery Refusal to sign informed consent form

Design outcomes

Primary

Measure	Time frame
Rate of cervical dilation and total duration of 1st, 2nd and 3rd stages of labour	—

Secondary

Measure	Time frame
Estimated blood loss, maternal side effects and APGAR scores of the newborn	—

Countries

Nigeria

Contacts

Public ContactDamian Chinedu Asogwa

Consultant Department of Obstetrics and Gyanecology AEFUTHA

doctorasogwa@yahoo.com+2348034266840

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026